CHICAGO -- Semaglutide (Ozempic) reduced glucose levels and weight among patients with type 1 diabetes and obesity, a randomized trial showed. In this 26-week, double-blind trial of 72 adults, 36% ...

Ozempic and Mounjaro are both very popular for weight loss at the minute, but there's one big difference between the two ...

Ozempic (semaglutide) and other GLP-1 medications have helped many people lose weight and manage chronic conditions like type ...

Semaglutide, the active ingredient in Ozempic, and other drugs in the same class have revolutionized the treatment of obesity and type 2 diabetes. Now, a clinical trial suggests the medicines can ...

When you hear the name Ozempic, you likely think of diabetes treatment. That makes sense, as semaglutide was first approved in 2017 to help people with type 2 diabetes regulate […] ...

More people with type 1 diabetes are using GLP-1s like Ozempic and Zepbound, a new study found. Researchers attribute the high demand to rising rates of obesity among people with type 1 diabetes.

Many people stop taking GLP-1 drugs like Ozempic within a year, but doing so often leads to weight regain. Here's what to ...

Ozempic and Zepbound are both prescription injections that are part of the GLP-1 drug class. They have different active ...

The diabetes drugs Ozempic and Wegovy have been linked to an increased risk of sudden vision loss and blindness due to a rare ...

An experimental pill may work just as well as injectable, Ozempic-style drugs at treating type 2 diabetes, early trial results suggest. The oral medication, called orforglipron, belongs to a class ...

Here’s how it works. GLP-1 agonists, the class of drug that includes Ozempic, may be useful for managing type 1 diabetes. (Image credit: Tatsiana Volkava via Getty Images) ...